← Eichor
Study identifier: NCT05551299 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy

Condition: Hilar Cholangiocarcinoma  ·  Sponsor: University of Leipzig

PhasePhase 4
Planned participants258
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Bile duct cancer is often diagnosed after curative options are no longer available. Stent therapy is used to keep the ducts open and can be combined with photodynamic therapy (PDT) to extend life expectancy. PDT requires an injection of photosensitizer after which light of a particular wavelength is applied endoscopically to kill the cancer cells. Drawbacks include not only high costs and poor availability, but foremost that patients have to avoid direct sunlight for a period of weeks. Radio frequency ablation (RFA) together with stent implantation constitutes an alternative by which the cancer cells are killed through heat, also applied endoscopically. The RFA technology is more widely available and easier to deploy. However, it has not been studied extensively and no randomized trials exist comparing the two methods. This trial will compare survival in patients with a particular bile duct cancer depending on whether they receive PDT or RFA. Moreover, data will be collected on side-effects and quality of life.

This description comes directly from the study's public registry record.

Talk to the study team

Albrecht Hoffmeister, Prof.Dr.med.  ·  +49-341-97-12240  ·  albrecht.hoffmeister@medizin.uni-leipzig.de

Marcus Hollenbach, Dr. med.  ·  +49-341-97-12362  ·  marcus.hollenbach@medizin.uni-leipzig.de

Always discuss trial participation with your own doctor first.

Locations (20)

Uniklinik RWTH Aachen, Medizinische Klinik IIIAachen, GermanyRecruiting
Universitätsklinikum Augsburg; III. Med. KlinikAugsburg, GermanyRecruiting
Vivantes Netzwerk für Gesundheit GmbH, Klinikum Friedrichshain, Innere Medizin/GastroenterologieBerlin, GermanyNot Yet Recruiting
Universitatsklinikum Bonn, Medizinische Klinik und Poliklinik IBonn, GermanyRecruiting
Universitätsklinikum Frankfurt, Medizinische Klinik 1Frankfurt, GermanyNot Yet Recruiting
Universitätsklinikum Freiburg, Medizinische Klinik II, Abteilung Gastroenterologie, Hepatologie, Endokrinologie & lnfektiologieFreiburg im Breisgau, GermanyRecruiting
Universitätsmedizin Greifswald Klinik für Innere Medizin AGreifswald, GermanyRecruiting
Site: Martin-Luther-Universitat Halle-Wittenberg, Universitätsklinik und Poliklinik für Innere Medizin IHalle, GermanyRecruiting
Klinikum Hanau; Klinik für Gastroenterologie, Diabetologie und InfektiologieHanau, GermanyRecruiting
KRH Klinikum Siloah, Klinik für GastroenterologieHanover, GermanyRecruiting
Klinikum St. Georg gGmbH; Klinik für Gastroenterologie, Hepatologie, Diabetologie und EndokrinologieLeipzig, GermanyRecruiting
University Hospital of Leipzig, Department of GastroenterologyLeipzig, GermanyRecruiting

+ 8 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05551299